277 related articles for article (PubMed ID: 22653811)
1. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.
Cayo MA; Cai J; DeLaForest A; Noto FK; Nagaoka M; Clark BS; Collery RF; Si-Tayeb K; Duncan SA
Hepatology; 2012 Dec; 56(6):2163-71. PubMed ID: 22653811
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
3. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
Yu L; Qiu S; Genest J
Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
[TBL] [Abstract][Full Text] [Related]
4. Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
Yang J; Wang Y; Zhou T; Wong LY; Tian XY; Hong X; Lai WH; Au KW; Wei R; Liu Y; Cheng LH; Liang G; Huang Z; Fan W; Zhao P; Wang X; Ibañez DP; Luo Z; Li Y; Zhong X; Chen S; Wang D; Li L; Lai L; Qin B; Bao X; Hutchins AP; Siu CW; Huang Y; Esteban MA; Tse HF
Stem Cell Reports; 2017 Mar; 8(3):605-618. PubMed ID: 28262545
[TBL] [Abstract][Full Text] [Related]
5. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia.
Okada H; Nakanishi C; Yoshida S; Shimojima M; Yokawa J; Mori M; Tada H; Yoshimuta T; Hayashi K; Yamano T; Hanayama R; Yamagishi M; Kawashiri MA
Sci Rep; 2019 Mar; 9(1):4695. PubMed ID: 30886174
[TBL] [Abstract][Full Text] [Related]
6. Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.
Nikasa P; Tricot T; Mahdieh N; Baharvand H; Totonchi M; Hejazi MS; Verfaillie CM
Stem Cells Dev; 2021 Jul; 30(14):714-724. PubMed ID: 33938231
[TBL] [Abstract][Full Text] [Related]
7. MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent.
Bjune K; Sundvold H; Leren TP; Naderi S
Atherosclerosis; 2018 Sep; 276():28-38. PubMed ID: 30025252
[TBL] [Abstract][Full Text] [Related]
8. iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
Zakharova IS; Shevchenko AI; Arssan MA; Sleptcov AA; Nazarenko MS; Zarubin AA; Zheltysheva NV; Shevchenko VA; Tmoyan NA; Saaya SB; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255763
[TBL] [Abstract][Full Text] [Related]
9. Restoration of Physiologically Responsive Low-Density Lipoprotein Receptor-Mediated Endocytosis in Genetically Deficient Induced Pluripotent Stem Cells.
Ramakrishnan VM; Yang JY; Tien KT; McKinley TR; Bocard BR; Maijub JG; Burchell PO; Williams SK; Morris ME; Hoying JB; Wade-Martins R; West FD; Boyd NL
Sci Rep; 2015 Aug; 5():13231. PubMed ID: 26307169
[TBL] [Abstract][Full Text] [Related]
10. Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
Omer L; Hudson EA; Hudgins LC; Boyd NL
Stem Cells Dev; 2021 Jun; 30(12):632-640. PubMed ID: 34029164
[TBL] [Abstract][Full Text] [Related]
11. Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia.
Si-Tayeb K; Idriss S; Champon B; Caillaud A; Pichelin M; Arnaud L; Lemarchand P; Le May C; Zibara K; Cariou B
Dis Model Mech; 2016 Jan; 9(1):81-90. PubMed ID: 26586530
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
13. An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.
Zhang L; McCabe T; Condra JH; Ni YG; Peterson LB; Wang W; Strack AM; Wang F; Pandit S; Hammond H; Wood D; Lewis D; Rosa R; Mendoza V; Cumiskey AM; Johns DG; Hansen BC; Shen X; Geoghagen N; Jensen K; Zhu L; Wietecha K; Wisniewski D; Huang L; Zhao JZ; Ernst R; Hampton R; Haytko P; Ansbro F; Chilewski S; Chin J; Mitnaul LJ; Pellacani A; Sparrow CP; An Z; Strohl W; Hubbard B; Plump AS; Blom D; Sitlani A
Int J Biol Sci; 2012; 8(3):310-27. PubMed ID: 22355267
[TBL] [Abstract][Full Text] [Related]
14. A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B.
Liu JT; Doueiry C; Jiang YL; Blaszkiewicz J; Lamprecht MP; Heslop JA; Peterson YK; Carten JD; Traktman P; Yuan Y; Khetani SR; Twal WO; Duncan SA
Commun Biol; 2023 Apr; 6(1):452. PubMed ID: 37095219
[TBL] [Abstract][Full Text] [Related]
15. Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene.
Gao J; Li J; Xu L; Yan CD; Knowles JW; Wu JC
Stem Cell Res; 2024 Aug; 78():103463. PubMed ID: 38852422
[TBL] [Abstract][Full Text] [Related]
16. Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism.
Barrett PH; Watts GF
Atheroscler Suppl; 2002 Mar; 2(3):1-4. PubMed ID: 11923121
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment.
Omer L; Hindi L; Militello G; Stivers KB; Tien KC; Boyd NL
Dis Model Mech; 2020 Apr; 13(4):. PubMed ID: 32005714
[TBL] [Abstract][Full Text] [Related]
18. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
[TBL] [Abstract][Full Text] [Related]
20. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
